GAMCO Investors’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-72,700
Closed -$796K 877
2017
Q2
$796K Buy
72,700
+48,700
+203% +$534K 0.01% 617
2017
Q1
$253K Hold
24,000
﹤0.01% 766
2016
Q4
$202K Hold
24,000
﹤0.01% 778
2016
Q3
$172K Hold
24,000
﹤0.01% 783
2016
Q2
$185K Hold
24,000
﹤0.01% 778
2016
Q1
$175K Hold
24,000
﹤0.01% 766
2015
Q4
$185K Hold
24,000
﹤0.01% 776
2015
Q3
$172K Hold
24,000
﹤0.01% 792
2015
Q2
$255K Hold
24,000
﹤0.01% 769
2015
Q1
$297K Hold
24,000
﹤0.01% 763
2014
Q4
$224K Hold
24,000
﹤0.01% 807
2014
Q3
$240K Hold
24,000
﹤0.01% 813
2014
Q2
$248K Hold
24,000
﹤0.01% 812
2014
Q1
$299K Hold
24,000
﹤0.01% 767
2013
Q4
$295K Hold
24,000
﹤0.01% 756
2013
Q3
$207K Hold
24,000
﹤0.01% 789
2013
Q2
$209K Buy
+24,000
New +$215K ﹤0.01% 766

Other funds holding ELOS

GAMCO Investors's ELOS Position: Q3 2017 in Review

GAMCO Investors sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 72,700 shares — an estimated $796K sold.

GAMCO Investors first reported a position in ELOS in Q2 2013 and held it in 17 quarters. The position peaked at $796K in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • GAMCO Investors reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • GAMCO Investors sold 72,700 Syneron Medical Ltd shares in Q3 2017, an estimated $796K.
  • GAMCO Investors first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 17 quarters.
  • GAMCO Investors's Syneron Medical Ltd position peaked at $796K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on GAMCO Investors's 13F filing for Q3 2017, filed 1 Nov 2017.